Despite Failed Phase 3 Study, FDA Staff Says Biogen’s ALS Drug May Have Clinical Benefit – Biogen (NASDAQ:BIIB)
Judge rejects Trump, rape accuser Carroll’s request for single defamation trial Reuters via biedexmarkets.com
Read More 1 minute read stockpicks Bears are confidently leading the market to the goal Share: In the long term, BABA seems to be forming a bearish trend. On the current…… byroger_fax1gxzp13/03/2023
